TC-99M SESTAMIBI AND IN-111 PENTETREOTIDE UPTAKE IN METASTATIC PAPILLARY THYROID-CARCINOMA

Authors
LEE J CUTRONE JA MARCUS CS
Citation
J. Lee et al., TC-99M SESTAMIBI AND IN-111 PENTETREOTIDE UPTAKE IN METASTATIC PAPILLARY THYROID-CARCINOMA, Clinical nuclear medicine, 20(10), 1995, pp. 867-868
Citations number
6
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
Clinical nuclear medicine → ACNP
ISSN journal
03639762
Volume
20
Issue
10
Year of publication
1995
Pages
867 - 868
Database
ISI
SICI code
0363-9762(1995)20:10<867:TSAIPU>2.0.ZU;2-W
Abstract
Approximately 25% of metastatic and recurrent differentiated (papillar y and follicular) thyroid carcinoma do not concentrate I-131 Nal. In s uch cases, diagnosis can be attempted with other radiopharmaceuticals. The authors present a case of recurrent papillary thyroid carcinoma t hat was welt visualized with Tc-99m sestamibi and In-111 pentetreotide ; but only poorly visualized by I-131 Nal.